Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sackett, J. F.
Right arrow Articles by Duff, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sackett, J. F.
Right arrow Articles by Duff, T. A.

Radiology, Vol 123, 779-782, Copyright © 1977 by Radiological Society of North America

ARTICLES

Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients

JF Sackett, CM Strother, CE Quaglieri, MJ Javid, AB Levin and TA Duff

Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid spaces. Side effects were reported in 67% of these; 39% were moderate or severe. Cervical injections monitored by fluoroscopy provide the most precise positioning of the medium. The benefits of metrizamide use outweigh its risk.


This article has been cited by other articles:


Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
J. Finsterer, D. Lubec, A. Verlicchi, and P. Samec
Facial Myocloni and Stroke as Late Sequelae of Metrizamide Myelography
J Neuropsychiatry Clin Neurosci, November 1, 1998; 10(4): 472a - 473.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1977 by the Radiological Society of North America.